Skip to content
← Full study record

NCT00112489 · MORE INFO

Limitations, agreements, and source contact

Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer · Source last updated 2018-09-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
mleventhal@gogstats.org
organization
NRG Oncology - Buffalo Office
phone
716-341-3408
title
Melissa Leventhal
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
mleventhal@gogstats.org
organization
NRG Oncology - Buffalo Office
phone
716-341-3408
title
Melissa Leventhal

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice